Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats

Objective Recent studies have demonstrated that gut microbiota was closely related to metabolic disorders such as type 2 diabetes. Oral antidiabetic medications including metformin, acarbose and sitagliptin lowered blood glucose levels via acting on the gastrointestinal tract. The aim of the study w...

Full description

Bibliographic Details

Published in:	BMJ Open Diabetes Research & Care
Main Authors:	Wei Liu, Jing Ma, Rilu Feng, Mei Yang, Minchun Zhang, Cheng Qian
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2019-05-01
Online Access:	https://drc.bmj.com/content/7/1/e000717.full